EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy

Wenli Ning, Yunhan Sun, Mingyang Li, Shilu Liu, Fangjie Yi, Hongfei Wang, Ruibing Bai, Dongdong Liu, Fen Zhao, Guiqiang Zhang, Xiao Fu

BMEMat · 23.03.2026

DOI: 10.1002/bmm2.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMEMat, online erschienen am 23.03.2026. Verfasst von Wenli Ning und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the promising potential of immunotherapy in oncology, its efficacy is often limited by tumor metabolic reprogramming‐driven immunosuppressive microenvironment. Specifically, the reprogramming of amino acid metabolism, such as glutamine metabolism and tryptophan metabolism, not only sustains tumor growth but also facilitates immune evasion. Herein, we engineered CMZD NPs, a ZIF‐8‐based nanoparticle co‐delivering a glutaminase inhibitor (CB‐839) and a tryptophan metabolism inhibitor (1‐MT) to synergistically disrupt tumor immunosuppression through metabolic reprogramming. This nanoparticle system effectively blocks the glutamine metabolic pathway, amplifies oxidative stress, induces mitochondrial dysfunction, and ultimately leads to tumor cell death. Furthermore, it triggers the immunogenic cell death (ICD) and activates the cGAS‐STING pathway. Simultaneous inhibition of tryptophan‐to‐kynurenine conversion reduced kynurenine accumulation and altered glutamine metabolism, thereby reversing the tumor immunosuppressive microenvironment. The enhanced ICD effect generates new antigens that promote dendritic cell maturation, thereby recruiting and activating cytotoxic T lymphocytes. Ultimately, this nanoparticulate immune therapy enhancer inhibits both primary and distant tumors. This dual amino acid metabolism‐targeting strategy holds promise for enhancing tumor immunogenicity and alleviating tumor‐induced immune suppression, thereby improving the efficacy of immunotherapy.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Ning, W., Sun, Y., Li, M., Liu, S., Yi, F., Wang, H., Bai, R., Liu, D., Zhao, F., Zhang, G., & Fu, X. (2026). A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy. BMEMat. https://doi.org/10.1002/bmm2.70083

Vancouver

Ning W, Sun Y, Li M, Liu S, Yi F, Wang H, et al. A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy. BMEMat. 2026. doi:10.1002/bmm2.70083

BibTeX
@article{Ning2026,
  author = {Ning, Wenli and Sun, Yunhan and Li, Mingyang and Liu, Shilu and Yi, Fangjie and Wang, Hongfei and Bai, Ruibing and Liu, Dongdong and Zhao, Fen and Zhang, Guiqiang and Fu, Xiao},
  title = {A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy},
  journal = {BMEMat},
  year = {2026},
  doi = {10.1002/bmm2.70083}
}
Kostenlos starten →